| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 422 / 428 | 1st | Q4 |
| Cancer Research | 232 / 233 | 0th | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Onkologie (Czech Republic)
Onkologie (Czech Republic) is Scopus-indexed (Q4, CiteScore 0). Published by SOLEN s.r.o..
Checked against the index lists dated .
ISSN 1802-4475Verify ISSN ↗1803-5345Verify ISSN ↗
Publisher: SOLEN s.r.o.
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Onkologie (Czech Republic) indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q4, CiteScore 0.
What quartile is Onkologie (Czech Republic) in Scopus?
Onkologie (Czech Republic) is Q4 in Oncology (rank 422 of 428) and Q4 in Cancer Research (rank 232 of 233), by CiteScore 2025.
What is the impact factor of Onkologie (Czech Republic)?
Onkologie (Czech Republic) is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0, quartile Q4, 1st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.116, quartile Q4, with an H-index of 4.
Who publishes Onkologie (Czech Republic) and what is its ISSN?
Onkologie (Czech Republic) is published by SOLEN s.r.o. Its print ISSN is 1802-4475 and its online ISSN is 1803-5345.
Is Onkologie (Czech Republic) in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Onkologie (Czech Republic) open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Onkologie (Czech Republic)? — open metrics via OpenAlex
Onkologie (Czech Republic) has an h-index of 4 and a 2-year mean of 0.07 citations per paper (OpenAlex). Its Scopus CiteScore is 0, quartile Q4. On 2-year citations it ranks #395 of 424 Scopus journals in Oncology.
Onkologie (Czech Republic) published 52 papers in 2025; its busiest recent year was 2020 with 87. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Onkologie (Czech Republic)? — latest 39 articles, 2024–2026
In its latest 39 research articles (2024–2026), authors are most often from Czechia (93.6%) and Germany (6.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Onkologie (Czech Republic)? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
- Author concentration93.6% of recent authorship from Czechia
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.